Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma

Multiple myeloma (MM) is a plasma cell malignancy defined by complex genetics and extensive patient heterogeneity. Despite a growing arsenal of approved therapies, MM remains incurable and in need of guidelines to identify effective personalized treatments. Here, we survey the ex vivo drug and immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Kropivsek, Klara, Kachel, Paul, Goetze, Sandra, Wegmann, Rebekka, Festl, Yasmin, Severin, Yannik, Hale, Benjamin D., Mena, Julien, van Drogen, Audrey, Dietliker, Nadja, Tchinda, Joëlle, Wollscheid, Bernd, Manz, Markus G., Snijder, Berend
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Resource
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212768/
https://www.ncbi.nlm.nih.gov/pubmed/37081258
http://dx.doi.org/10.1038/s43018-023-00544-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212768/
https://www.ncbi.nlm.nih.gov/pubmed/37081258
http://dx.doi.org/10.1038/s43018-023-00544-9

Ejemplares similares